What does DR. SORGELOOSE PETER do?

DR. SORGELOOSE PETER is a general practice in Gent. Private Limited, started on 13 September 2001, 1 establishment.

What is the address of DR. SORGELOOSE PETER?

The registered office of DR. SORGELOOSE PETER is located at Emiel Lossystraat 60, 9040 Gent.

Is DR. SORGELOOSE PETER still active?

Yes. According to the CBE (31 October 2026) DR. SORGELOOSE PETER is active, legal situation “Normale toestand”, started on 13 September 2001.

Is DR. SORGELOOSE PETER registered on Peppol?

Yes, DR. SORGELOOSE PETER is registered on the Peppol network with ID 0208:0475643359.

What is the enterprise number of DR. SORGELOOSE PETER?

The enterprise number of DR. SORGELOOSE PETER is BE0475643359.

When was DR. SORGELOOSE PETER founded?

DR. SORGELOOSE PETER was founded on 13 September 2001.

Who are the directors of DR. SORGELOOSE PETER?

According to the 2025 annual accounts, the directors of DR. SORGELOOSE PETER are: Peter Sorgeloose.

Is DR. SORGELOOSE PETER a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 13 September 2001; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. SORGELOOSE PETER make in 2025?

DR. SORGELOOSE PETER posted a profit after taxes of € 156,031 in financial year 2025.

What is the revenue of DR. SORGELOOSE PETER?

As a small company, DR. SORGELOOSE PETER is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 245,947.

DR. SORGELOOSE PETER (Private Limited) - Gent

Dossier DR. SORGELOOSE PETER, printed on 1 November 2026 from databakkes.be/en/0475643359/dr-sorgeloose-peter. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. SORGELOOSE PETER from Gent, company number BE0475643359, closed financial year 2025 with a result of € 156,031 after tax. For that financial year DR. SORGELOOSE PETER recorded a gross margin of € 245,947 and equity of € 600,651. Compared with financial year 2024, the result moved from € 129,043 to € 156,031. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 28, 2026.

What it is worth Growing

€ 600,651

▲ 5% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 156,031

▲ 21% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 656,943

▲ 50% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 128,142 paid out

82 % of the profit went to the shareholders, the rest stayed in the company.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 2,266

▲ 57% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 58,158

▲ 196% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 147,135 Gross margin 2022: € 147,135 First fiscal year in the series	€ 142,130 Gross margin 2023: € 142,130 ▼ 3% vs 2022 (€ 147,135) Unfavourable step	€ 210,159 Gross margin 2024: € 210,159 ▲ 48% vs 2023 (€ 142,130) Favourable step	€ 245,947 Gross margin 2025: € 245,947 ▲ 17% vs 2024 (€ 210,159) Favourable step	▲ 17%
Profit after taxes	€ 83,151 Profit after taxes 2022: € 83,151 First fiscal year in the series	€ 79,997 Profit after taxes 2023: € 79,997 ▼ 4% vs 2022 (€ 83,151) Unfavourable step	€ 129,043 Profit after taxes 2024: € 129,043 ▲ 61% vs 2023 (€ 79,997) Favourable step	€ 156,031 Profit after taxes 2025: € 156,031 ▲ 21% vs 2024 (€ 129,043) Favourable step	▲ 21%
Equity	€ 363,721 Equity 2022: € 363,721 First fiscal year in the series	€ 443,719 Equity 2023: € 443,719 ▲ 22% vs 2022 (€ 363,721) Favourable step	€ 572,762 Equity 2024: € 572,762 ▲ 29% vs 2023 (€ 443,719) Favourable step	€ 600,651 Equity 2025: € 600,651 ▲ 5% vs 2024 (€ 572,762) Favourable step	▲ 5%
Total debts	€ 47,331 Total debts 2022: € 47,331 First fiscal year in the series	€ 55,143 Total debts 2023: € 55,143 ▲ 17% vs 2022 (€ 47,331) Unfavourable step	€ 21,096 Total debts 2024: € 21,096 ▼ 62% vs 2023 (€ 55,143) Favourable step	€ 142,097 Total debts 2025: € 142,097 ▲ € 121,001 vs 2024 (€ 21,096) Unfavourable step	▲ € 121,001
Cash	€ 131,366 Cash 2022: € 131,366 First fiscal year in the series	€ 307,363 Cash 2023: € 307,363 ▲ 134% vs 2022 (€ 131,366) Favourable step	€ 437,955 Cash 2024: € 437,955 ▲ 42% vs 2023 (€ 307,363) Favourable step	€ 656,943 Cash 2025: € 656,943 ▲ 50% vs 2024 (€ 437,955) Favourable step	▲ 50%
Land & buildings	€ 107,030 Land & buildings 2022: € 107,030 First fiscal year in the series	€ 90,482 Land & buildings 2023: € 90,482 ▼ 15% vs 2022 (€ 107,030) Unchanged	€ 74,499 Land & buildings 2024: € 74,499 ▼ 18% vs 2023 (€ 90,482) Unchanged	€ 58,517 Land & buildings 2025: € 58,517 ▼ 21% vs 2024 (€ 74,499) Unchanged	▼ 21%
Retained profit	€ 351,021 Retained profit 2022: € 351,021 First fiscal year in the series	€ 431,019 Retained profit 2023: € 431,019 ▲ 23% vs 2022 (€ 351,021) Favourable step	€ 560,062 Retained profit 2024: € 560,062 ▲ 30% vs 2023 (€ 431,019) Favourable step	€ 587,951 Retained profit 2025: € 587,951 ▲ 5% vs 2024 (€ 560,062) Favourable step	▲ 5%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 128,142 Dividend 2025: € 128,142 Unchanged (€ 0) Unchanged
Bank debt	€ 8,138 Bank debt 2022: € 8,138 First fiscal year in the series	€ 2,736 Bank debt 2023: € 2,736 ▼ 66% vs 2022 (€ 8,138) Favourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 2,736) Favourable step	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 411,052 Balance sheet total 2022: € 411,052 First fiscal year in the series	€ 498,862 Balance sheet total 2023: € 498,862 ▲ 21% vs 2022 (€ 411,052) Unchanged	€ 593,858 Balance sheet total 2024: € 593,858 ▲ 19% vs 2023 (€ 498,862) Unchanged	€ 742,747 Balance sheet total 2025: € 742,747 ▲ 25% vs 2024 (€ 593,858) Unchanged	▲ 25%

Key figures of DR. SORGELOOSE PETER, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. SORGELOOSE PETER?

What happened at DR. SORGELOOSE PETER in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 28, 2026 New annual accounts for financial year 2025: profit of € 156,031 (▲ 21% vs 2024). filed late Source: NBB ↗
Sep 13, 2001 Start of the company according to the CBE. KBO
Aug 31, 2001 New establishment in Gent. KBO

In short

From € 83,151 profit in 2022 to € 156,031 profit in 2025.

Paid € 197,302 in corporate taxes since 2022.

Best year ever: 2025, with € 156,031 profit.

Paid out € 128,142 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Peter Sorgeloose

DR. SORGELOOSE PETER

Behind DR. SORGELOOSE PETER is Peter Sorgeloose.

Directors

According to the 2025 annual accounts

Peter Sorgeloose

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Emiel Lossystraat 60

9040 Gent

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0475.643.359
VAT number: BE 0475.643.359
Registered office: Emiel Lossystraat 60, 9040 Gent
Names & denominations: DR. SORGELOOSE PETER
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 13 September 2001
Peppol: Active · Active since 9 Jul 2025
Activities · NACE: Activiteiten van huisartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗